Independent Medical Education supports healthcare professionals through independent education and practice-improvement initiatives to strengthen clinical knowledge, care coordination, and patient outcomes.
The funder removed the Alzheimer’s Disease RFP link for two primary care opportunities and added Independent Medical Education RFP links for Lupus Nephritis and Diabetic Macular Edema.
Funder: Roche
Due Dates: November 22, 2026 (DME and Lupus Nephritis RFPs) | At least 60 days before activity start (All requests)
Funding Amounts: Up to $250,000 in support available for each RFP: Diabetic Macular Edema and Lupus Nephritis
Summary: Genentech supports independent healthcare professional education, including practice-improvement initiatives addressing diabetic macular edema and lupus nephritis.
Key Information: Both RFPs require U.S.-based, accredited CME/CE providers in good standing and U.S.-based educational initiatives.
Genentech, a member of the Roche Group, supports Independent Medical Education to strengthen healthcare professionals’ knowledge, advance excellence in healthcare, and improve patient outcomes. Independent providers include community hospitals, academic centers, societies, associations, and medical education and communication companies. Activity organizers retain sole control over the agenda, content, faculty, and execution, without Genentech guidance.
Two targeted RFPs seek practice- and quality-improvement education. The Diabetic Macular Edema (DME) opportunity focuses on upskilling comprehensive/general ophthalmologists and improving interprofessional coordination in rural and community settings lacking retinal subspecialists. The Lupus Nephritis opportunity addresses early recognition, renal monitoring, and coordination across primary care, rheumatology, and nephrology. Both require broad, scalable educational value rather than localized operational consulting or practice-management support.